EUPATI – European Patients Academy

Slides:



Advertisements
Similar presentations
Service user participation in clinical trials Partnership or Co-option? Dr. Jan Wallcraft Operational Manager of SURGE (Service User Research Group for.
Advertisements

European Patients Academy on Therapeutic Innovation – The project is receiving support from the Innovative.
PATIENTS FOR PRIMARY CARE – WHY WE CANNOT DO IT ALONE Anders Olauson, EPF President Agrenska Chairman The Future of Primary Care in Europe IV, Gothenborg,
The evolving role of real-world evidence to support policy and practice CADTH 2015.
Building Strong Library Associations Programme Programme Overview Naomi Haasbroek SCECSAL Conference, Botswana, December 2010.
THE ROLE OF ALZHEIMER ASSOCIATIONS IN CAMPAIGNING FOR CHANGE Marc Wortmann Alzheimer’s Disease International.
December 2010iTEC - Designing the future classroom1 Virginija Birenienė iTEC community moderator iTEC Edukata tools in Education.
European Public Health Alliance Ilze Mūrniece Project assistant European Public Health Alliance Civic Alliance – Latvia Meeting of Anti-Poverty Network.
May 2015 European Patients’ Academy: Outline & Status Update The project is receiving support from the Innovative Medicines Initiative Joint Undertaking.
VITA- Virtual Learning for the Management of successful SMEs LEONARDO DA VINCI PROJECT – TRANSFER OF INNOVATION January 2009 – December PTI-LEO
Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.
Good Participatory Practice UNAIDS & AVAC Document Pauline Irungu Global Campaign for Microbicides.
September 13, 2007SGH&M2B International&Training Workshop What does the European Technology Platform “Innovative Medicines initiative” offer? Vitalijs.
HTA Benefits and Risks Dr Bernard Merkel European Commission.
Volservnet Voluntary Services and Networking A project in collaboration with the Ministry of Health, the Elderly and Community Care.
The industrial relations in the Commerce sector EU Social dialogue: education, training and skill needs Ilaria Savoini Riga, 9 May 2012.
Guidelines Recommandations. Role Ideal mediator for bridging between research findings and actual clinical practice Ideal tool for professionals, managers,
April 2016 European Patients’ Academy: Outline & Status Update The project is receiving support from the Innovative Medicines Initiative Joint Undertaking.
– European Patients’ Academy on Therapeutic Innovation The project is receiving support from the.
EUPATI Training Course Patient Experts in Medicines Research & Development The project is receiving support from the Innovative Medicines Initiative Joint.
Comparative analysis of the National Rural Networks (NRNs) in the EU Member States Martin Law Contact Point of the European Network for Rural Development.
 The Work of Civil Society in the Field of HIV Prevention Brussels, 23 February 2011 The Work of European AIDS Treatment Group (EATG) 1.
European Patients’ Academy on Therapeutic Innovation – The project is receiving support from the.
The Pan-African Statistics Programme (PAS)
Disclosure UK Talking about Transparency.
Challenges and opportunities for professional acupuncturists in the UK
DG Regional and Urban Policy
Manual for Trainers using „EUPATI Starter Kits“ for Mini Courses based on the EUPATI Toolbox Material This presentation is a derivative of the EUPATI Toolbox.
PATIENT ACCESS + EMPOWERMENT Priorities
SNOMED CT Education SIG: Strategic Plan Review
Patient Involvement in the HTA Decision Making Process
SUSTAINABILITY PLANNING
EUPATI guidance document for patient involvement in industry-led medicines R&D Kay Warner on behalf of the EUPATI team.
EU Ambassador Cities. EU Ambassador Cities Manifesto on Citizen Engagement The Manifesto on Citizen Engagement is the outcome of a co-creation process.
Research4Life Programmes: Similarities and Differences!
From ambition to reality
EU Ambassador Cities. EU Ambassador Cities Manifesto on Citizen Engagement The Manifesto on Citizen Engagement is the outcome of a co-creation process.
Disclosure UK Talking about Transparency.
Participation of Patient Advocates in Community Advisory Boards A case-study: the HIV European Community Advisory Board (ECAB)
Regional and Bilateral cooperation instruments
The Internal Market Information (IMI) System –
Martin Müller InRoad Coordinator InRoad
Introduction to TransCelerate
Community Advisory Board: a definition
ERASMUS+ Capacity-building in Higher Education
European TRAINING FOUNDATION
Helpful Hints for action to prevent elder abuse
Research for all Sharing good practice in research management
European Centre for Modern Languages
America’s Energy Link Intro self
Knowledge Translation
Innovative Medicines Initiative:
Support for the REFIT actions for the ELD
ECVAM as EU-RL according to 2010/63
Consortium for Entrepreneurship Education
The role of the ECCP (1) The involvement of all relevant stakeholders – public authorities, economic and social partners and civil society bodies – at.
Innovative Learning & Development Specialists
The InWEnt Blended-learning approach; GC21 as an e-learning and Blended-learning platform 22/02/2019 An introduction course on InWEnt Blended-learning.
Kaisa Immonen EPF Director of Policy
Harmoni-CA may play the role of “interface” for facilitating access to toolboxes in support of the WFD implementation However, to date it only addresses.
The practicalities of PPI
EUnetHTA Assembly May 2018.
NICE has many methods and processes
IMI – an opportunity to implement research for patients and with patients Catherine Brett European Parliament Interest Group on Allergy and Asthma
Preliminary findings May 2019, GLAD meeting, Ottawa
European waters - assessment of status and pressures 2018
An Agency Perspective on Plain Language Summaries of Publications
Dance Ambassador Application Guidance
Webinar, 21th September 2018, 11:30 CET
An Agency Perspective on Plain Language Summaries of Publications
Presentation transcript:

EUPATI – European Patients Academy Matthew May EUPATI Programme Coordinator 05 May 2017

Mission: Empowering patients for their key role in health-related research Competent authorities Policy makers /Research Policy Public Research subject Info provider Advisor Reviewer Co-researcher Driving force Clinical Research Research Ethics Committees HTA agencies & committees

Patient involvement in medicines R&D Protocol synopsis Trial Steering Committee Information to participants Setting research priorities Data MonitoringCommittee Protocol design Regulatory Affairs Investigator meetings High expertise in disease area required Research Priorities Research design and Planning Research conduct and operations Dissemination Communication Post-approval Ethics Review Study Reporting Patient Information Fundraising for research Post-Study Communication Medium expertise in disease area required Informed Consent Practical Considerations Health Technology Assessment

Public-Private-Partnership

EUPATI is addressing three audiences: The plan EUPATI Patient Experts Training Course -- for expert patients 100 patient experts >170.000 users to date 2 courses done, 96 Fellows Different approach 10 languages English EUPATI Educational Toolbox -- for patient advocates 12.000 patient advocates English French German Spanish Polish Italian Russian EUPATI Internet Library -- for the health-interested public 100.000 individuals

Training leaders and creating a movement…

Two EUPATI Courses: Mission accomplished! 96 graduates completed the two courses 58 disease areas, 31 countries 3rd course to start in September 2017 Ingrid K

EUPATI Fellows has created influencers and leaders Role Before Course EUPATI Post Course Member of patient organisation, not actively involved 17% 2% Active role in a patient organisation 62% 71% Leadership role in a patient organisation Employee of a patient organisation 25% 23% Volunteer role in a patient organisation 60% 67% Presenting at conferences, workshops etc. 63% 83% Advising a pharmaceutical company 13% 44% Advising a regulatory agency 21% 42% Advising a reimbursement agency 4% 8% We have surveyed 52 of the 83 fellows that had completed the two courses until last week. If you compare their roles and activities before they started with our course, and after they completed the course, you can see that the course has encouraged them to take a leadership role in advocacy, and many of them have then started to advise pharma companies, regulatory agencies or HTA bodies as patient experts. Source: The EUPATI Fellow Experience Poll, December 2016, 52 respondents (83 fellows)

Educating the wider community…

EUPATI Toolbox on Medicines R&D in 10 languages: Huge demand In English, French, Italian, Spanish, German, Polish, Russian, Dutch (2 more to come) >168.000 unique users from 149 countries (Jan 16 –May 2017)

EUPATI Toolbox on Medicines R&D: >3.500 content items PowerPoints Articles The Toolbox is not just a medicines R&D Encyclopedia, it can be a tool for self-learning, or it can be a tool for teaching others, for trainers. With this in mind, we’ve included tools in a range of formats, to try and suit as many audiences as possible. As a result you will find: Articles [short description] PowerPoints [short description] Infographics [short description] Factsheets [short description] In the coming months, we hope to also add XX, XX, and XX. Infographics Fact sheets

EUPATI Mini-Course Starter Kits to run training days Core set of PPT slides in specific area of patient involvement, plus links into EUPATI Toolbox, Case Studies + Trainers Manual! Research design and Planning Research Priorities Research conduct and operations Dissemination Communication Post-approval Setting research priorities Protocol synopsis Protocol design Trial Steering Committee Information to participants Data MonitoringCommittee Investigator meetings Regulatory Affairs Fundraising for research Practical Considerations Patient Information Informed Consent Ethics Review Study Reporting Health Technology Assessment Post-Study Communication

EUPATI Mini-Course Starter Kits to run training days

Making sure it’s right…

EUPATI Production & Review Process: Don’t tell us we’ve made our lives easy!

Creating networks on the country level…

18+ EUPATI National Platforms bring all stakeholders together in countries address educational needs in R&D disseminate EUPATI’s training material to patient organisations National platforms set up in AT, FR, DE, IE, IT, LU, MT, PL, ES, CH, UK, DK, SK, PT Additional platform initiatives ongoing in BE, NO, GR, RO, SRB

Providing guidance and frameworks…

EUPATI Guidance for patient involvement and interaction – Why? Overarching guidance on meaningful and ethical interaction is missing in many areas, especially in R&D Existing codes/regulations hold mostly legal & ethical content, i.e. collaboration, communication, funding Do not cover patient involvement in R&D e.g. EFPIA, EATG code, PCWP framework, ECAB, EMA framework, HTAi Language needs to be more directive towards patient involvement Clear default statement that collaboration is allowed unless expressly forbidden

EUPATI Guidances are supporting patient interaction in R&D and regulatory affairs Following an extensive consultation of the community, EUPATI has developed guidances for the interaction of patient organisations… in industry-led R&D with HTA bodies in regulatory processes in ethics committees See EUPATI.eu > Resources > Guidances or http://eupati.eu/guidances

The “New” EUPATI Programme EPF-led, permanent programme in the PPP spirit 3rd EUPATI Patient Expert Training Course EUPATI Toolbox in all languages “Mini-Course Starter Kits” and capacity building Content updates (~10 Toolbox elements updated p.a.) National Platforms Evolution! Jan G IMI Call 1: not funded 2-stage application, consortium building EUPATI IMI Project 2012-2016: patient-led PPP of patients, academia, NGOs and industry EUPATI Programme 2010 2011 2012 2013 2014 2015 2016 2017 2018

A new PPP

Web: www.eupati.eu Twitter: @eupatients as well as: